# Quaker Partners: portfolio, investments and team > Quaker Partners is a vc firm based in United States. 58 investments on record, latest May 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/quaker-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Quaker Partners Last cheque observed May 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet New fund $35M, Nov 2016 VC firm Seed Series A Series B Healthtech Connected Health Health-tech Cheques on record **0%** of best year **0** **cheques in 12 months**, 58 on record Since the last cheque **2706** days **00** hrs **00** min **00** sec Median round **$25M** Rounds led **0 of 58** Exits **6 from the portfolio** Mostly in **United States, 100%** Pitch Quaker Partners ## Quaker Partners highlights - 01 58 rounds on record - 02 Mostly Series A and Series B: 53% of its rounds - 03 6 exits from the portfolio ## What they do > Filed 1 private fund offering with the SEC, the most recent in 2016-11 From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth - **Sectors:** Healthtech Connected Health Health-tech - **Based in:** Philadelphia, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **58 appearances** - **2019** 2 rounds - **May** **[Intact Vascular](https://millionrounds.com/company/intact-vascular)** US · Massdevice **$25M** With 3 others - **May** **[Vesper Medical](https://millionrounds.com/company/vesper-medical)** US · Massdevice **$37M** With 3 others - **2018** 2 rounds - **May** **[Vesper](https://millionrounds.com/company/vesper)** Series A · US · Fiercebiotech **$11M** With 1 other - **May** **[Rapid Micro](https://millionrounds.com/company/rapid-micro)** US · FinSMEs **$60M** With 6 others - **2017** 1 round - **Jan** **[Intact Vascular](https://millionrounds.com/company/intact-vascular)** Series B · US · FinSMEs **$7.1M** With 1 other - **2015** 3 rounds - **May** **[Intact Vascular](https://millionrounds.com/company/intact-vascular)** Series B · US **$38M** With 2 others - **Apr** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Series C · US **$25M** With 5 others - **Apr** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series F · US **$34M** With 7 others - **2014** 2 rounds - **May** **[Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics)** Series B · US **$7.0M** With 3 others - **Apr** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Venture · US **$6.0M** With 4 others - **2013** 3 rounds - **Sept** **[PreCision Dermatology](https://millionrounds.com/company/precision-dermatology)** Debt · US · pehub.com **$67M** With 7 others - **Jun** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Series B · US · finsmes.com **$33M** With 4 others - **Apr** **[RainDance Technologies](https://millionrounds.com/company/raindance-technologies)** Series E · US · finsmes.com **$20M** With 4 others - **2012** 3 rounds - **Dec** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series E · US · regadobio.investorroom.com **$51M** With 8 others - **Sept** **[Intact Vascular](https://millionrounds.com/company/intact-vascular)** Series A · US · intactvascular.com **$16M** With 1 other - **Mar** **[Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics)** Series B · US · prnewswire.com **$28M** With 4 others - **2011** 3 rounds - **Jun** **[NovaSom](https://millionrounds.com/company/novasom)** Series D · US · novasom.com **$35M** With 2 others - **May** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series E · US · marketwire.com **$30M** With 7 others - **Jan** **[RainDance Technologies](https://millionrounds.com/company/raindance-technologies)** Series D · US · finsmes.com **$38M** With 3 others - **2010** 7 rounds - **Sept** **[Celator Pharmaceuticals](https://millionrounds.com/company/celator-pharmaceuticals)** Series D · US · celatorpharma.com **$20M** With 6 others - **Aug** **[Achillion Pharmaceuticals](https://millionrounds.com/company/achillion-pharmaceuticals)** Venture · US · ir.achillion.com **$50M** With 3 others - **Aug** **[TetraLogic Pharmaceuticals](https://millionrounds.com/company/tetralogic-pharmaceuticals)** Series C · US · fiercebiotech.com **$32M** With 7 others - **Jun** **[Corridor Pharmaceuticals](https://millionrounds.com/company/corridor-pharmaceuticals)** Series A · US · finance.yahoo.com **$13M** With 7 others - **May** **[TearScience](https://millionrounds.com/company/tearscience)** Series C · US · onbiovc.com **$45M** With 5 others - **Jan** **[Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics)** Series A · US · onbiovc.com **$24M** With 2 others - **Jan** **[BioLeap](https://millionrounds.com/company/bioleap)** Series A · US · eon.businesswire.com **$5.0M** With 1 other - **2009** 7 rounds - **Dec** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series D · US · regadobio.com **$40M** With 5 others - **Oct** **[Sleep Solutions](https://millionrounds.com/company/sleep-solutions)** Series F · US · onbiovc.com **$20M** With 5 others - **Oct** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series D · US · onbiovc.com **$30M** With 7 others - **Oct** **[TransEnterix](https://millionrounds.com/company/transenterix)** Series B · US · onbiovc.com **$55M** With 5 others - **Oct** **[Corridor Pharmaceuticals](https://millionrounds.com/company/corridor-pharmaceuticals)** Series A · US · venturedeal.com **$11M** With 3 others - **Aug** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Series A · US · onbiovc.com **$19M** With 3 others - **Jun** **[Cempra](https://millionrounds.com/company/cempra)** Series C · US · onbiovc.com **$46M** With 5 others - **2008** 6 rounds - **Nov** **[Tengion](https://millionrounds.com/company/tengion)** Series C · US **$21M** With 7 others - **Oct** Seed · findarticles.com **$2.3M** With 3 others - **Oct** **[Corridor Pharmaceuticals](https://millionrounds.com/company/corridor-pharmaceuticals)** Seed · US · findarticles.com **$2.3M** With 3 others - **Oct** **[Biolex Therapeutics](https://millionrounds.com/company/biolex-therapeutics)** Series D · US · mitsuiventures.com **$60M** With 10 others - **Jul** **[Celator Pharmaceuticals](https://millionrounds.com/company/celator-pharmaceuticals)** Series C · US **$23M** With 5 others - **Jul** **[NuPathe](https://millionrounds.com/company/nupathe)** Series B · US **$30M** With 6 others - **2007** 9 rounds - **Nov** **[Tranzyme](https://millionrounds.com/company/tranzyme)** Venture · US **$20M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **3 named** DA **Dean Adler** Member of the General Partner of the Sole Member of a General Partner i Filing they signed IL **Ira Lubert** Member of the General Partner of the Sole Member of a General Partner i Filing they signed JE **Jeff Elowe** Sole Member of a General Partner i Filing they signed We also hold **6** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **6 in all** **[PreCision Dermatology](https://millionrounds.com/company/precision-dermatology)** Bought by Valeant Pharmaceuticals International **$500M** Feb 2014 **[NuPathe](https://millionrounds.com/company/nupathe)** Bought by Endo Health Solutions **$105M** Dec 2013 **[EKR Therapeutics](https://millionrounds.com/company/ekr-therapeutics)** Bought by Cornerstone Therapeutics **$150M** May 2012 **[NuPathe](https://millionrounds.com/company/nupathe)** Listed **Undisclosed** Aug 2010 **[Tengion](https://millionrounds.com/company/tengion)** Listed **Undisclosed** Apr 2010 **[BioRexis](https://millionrounds.com/company/biorexis)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Feb 2007 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$35M** raised in Nov 2016 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$25M** the round, not its cheque Led 0 of 58 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** May 2019 - **Exits:** 6 from the portfolio Rounds by stage said on their site - Series A said *13* - Series B said *12* - Series C *11* - Series D *6* - Venture *5* - Seed said *-* - Growth said *-* Cheques by year Led Joined 2002 2019 Often in the room with - [Domain Associates](https://millionrounds.com/fund/domain-associates) 9 - [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) 9 - [Intersouth Partners](https://millionrounds.com/fund/intersouth-partners) 7 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 6 - [BDC Capital](https://millionrounds.com/fund/bdc-venture-capital) 5 - [Investor AB](https://millionrounds.com/fund/investor-ab) 5 **Pitching Quaker Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Quaker Partners. A count of rooms they were both in, not a relationship either has claimed. [**Domain Associates** VC firm **9** rounds together](https://millionrounds.com/fund/domain-associates)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **9** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**Intersouth Partners** VC firm **7** rounds together](https://millionrounds.com/fund/intersouth-partners)[**New Enterprise Associates** VC firm **6** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**BDC Capital** VC firm **5** rounds together](https://millionrounds.com/fund/bdc-venture-capital)[**Investor AB** VC firm **5** rounds together](https://millionrounds.com/fund/investor-ab)[**Kleiner Perkins Caufield & Byers** VC firm **5** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Longitude Capital** VC firm **5** rounds together](https://millionrounds.com/fund/longitude-capital)[**MedImmune Ventures** Corporate VC **5** rounds together](https://millionrounds.com/fund/medimmune-ventures)[**Red Abbey Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/red-abbey-venture-partners)[**Acidophil** VC firm **4** rounds together](https://millionrounds.com/fund/acidophil)[**Polaris Partners** VC firm **4** rounds together](https://millionrounds.com/fund/polaris-partners) ## Recently backed The latest companies Quaker Partners put money into. [**Vesper Medical** $37M · May 2019](https://millionrounds.com/company/vesper-medical)[**Vesper** $11M · May 2018](https://millionrounds.com/company/vesper) ## Quick answers about Quaker Partners ### What does Quaker Partners invest in? Quaker Partners invests most often at Series A and Series B (53% of the rounds on record), in sectors such as Healthtech, Connected Health and Health-tech. ### How active is Quaker Partners? 58 investments on record, 0 of them in the last 12 months. The most recent was in May 2019. ### What has Quaker Partners invested in recently? Its most recent investments on record: Intact Vascular (Undisclosed round, May 2019), Vesper Medical (Undisclosed round, May 2019) and Vesper (Series A, May 2018). ### How big are Quaker Partners's cheques? The median round it joins is $25M. ### Does Quaker Partners lead rounds? Rarely, if at all: none of its 58 investments on record names it as the lead. ### Where does Quaker Partners invest? Most of the companies it backs are in the United States (100%). ### Is Quaker Partners investing now? No investments in the last 12 months; the latest was in May 2019. ### Who does Quaker Partners invest alongside? Most often Domain Associates (9 rounds together), Johnson & Johnson Development Corporation (JJDC) (9 rounds together) and Intersouth Partners (7 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=quaker-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=quaker-partners)